- Technical innovations
- Open Access
Minimally invasive hybrid surgery combined with endoscopic and thoracoscopic approaches for submucosal tumor originating from thoracic esophagus
© Daiko et al.; licensee BioMed Central. 2015
Received: 19 June 2014
Accepted: 8 January 2015
Published: 12 February 2015
Despite the efficacy of molecular targeted therapy, surgical resection remains the only curative primary treatment for gastrointestinal stromal tumors (GISTs). However, in cases when the tumor originates from the thoracic esophagus, conventional transthoracic approach is highly invasive.
All procedures were performed with patients in a prone position through a double-lumen endotracheal tube for single-lung ventilation. First, to clarify the resection layer between the tumor and mucosal layer of the esophagus, a sodium hyaluronate solution colored with indigo carmine was injected into the submucosa via the esophagoscopic approach. Second, we thoracoscopically divided the longitudinal muscle of the esophagus and enucleated the tumor through three ports by dissecting along the artificially colored submucosa, thereby minimizing accidentally opening of the esophageal mucosa. Third, we sutured the divided longitudinal muscle layer and removed the tumor from the thoracic cavity.
Four tumors, including one GIST, were successfully resected via this hybrid approach. The mean surgical time was 137.7 min (range, 60–231 min), and the mean blood loss was 21.2 ml (range, 3–65 ml). No perioperative complications occurred, including with accidental opening of the esophageal mucosa.
Our minimally invasive hybrid surgery combined with esophagoscopic and thoracoscopic approaches demonstrated successful resection. This surgery could have advantages both for curing esophageal submucosal tumor and for minimizing surgical invasiveness.
Even with the recent advances in diagnostic modalities, a correct diagnosis of submucosal tumors (SMTs) originating from the esophagus is still challenging [1-4]. In cases when the tumor is larger than 3 cm in size, surgical resection is recommended for definitive diagnosis and treatment due to a higher risk of malignancy . For the surgical resection of gastrointestinal stromal tumors (GISTs) originating from the thoracic esophagus, thoracotomy with esophagectomy is still the preferred approach, particularly in cases when the tumor is relatively large in size. However, this procedure is usually accompanying large operation scar with reconstruction of the gastric tube. This results in postoperative pain and a relatively higher incidence of accidental opening of the esophageal mucosa [5,6].
With patients in a prone position, thoracoscopic esophagectomy has been reported to be safe and effective, resulting in sufficient surgical outcomes for cancer of the thoracic esophagus . The thoracoscopic approach with patients in a prone position provides an excellent surgical field that makes dissection easier because the physical retraction of organs is not required. Herein, we present the surgical procedures and outcomes of our minimally invasive hybrid approach combined with esophagoscopy and thoracoscopy for enucleating SMTs originating from the thoracic esophagus.
Human rights statement and informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study. Patient data were retrospectively evaluated after receiving approval from our institution’s investigational review board with the approval code of 012-0045.
All procedures were performed with patients under general anesthesia through a double-lumen endotracheal tube for single-lung ventilation. After intubation, each patient was placed in a prone position on a surgical bean bag, and the patient’s right arm was raised cranially. The surgeon and camera surgeon stood on the patient’s right side. The esophagoscopist stood at the patient’s head (right side), while the endoscopy cart with the monitor was positioned on the other side. Written informed consents were obtained from the patients for the publication of this report and any accompanying images.
Thoracoscopy through a three-port approach was sufficient to obtain optical dissection of the submucosal layer, which was artificially colored blue with MucoUp™ (Figure 1).
Clinical characteristics and surgical outcomes of four patients
Location of tumor
Size of tumor (cm)
Operation time (min)
Blood loss (ml)
Number of ports
Discharge after operation (day)
Immunohistopathological staining and pathological diagnosis of the tumor
Because of similar clinical, endoscopic, and radiographic appearances, a correct diagnosis of SMTs originating from the esophagus is often challenging, even with clinically apparent symptoms. Although SMTs of esophageal origin share similar clinical and radiographic characteristics, leiomyoma, leiomyosarcoma, and GISTs are distinct pathologic entities. Therefore, a correct diagnosis of SMTs originating from the esophagus is pivotal for the further management of patients with these entities. To clearly diagnose SMTs originating from the esophagus, several diagnostic methods are available. Because GISTs are fluorodeoxyglucose (FDG)-avid, FDG positron emission tomography (PET) scanning may be used to differentiate GISTs from leiomyoma . Furthermore, GISTs can be reliably identified preoperatively by endoscopic ultrasound (EUS)-guided FNA. However, even EUS-guided FNA lacks the capacity to differentiate between benign and malignant tumors, and normal findings do not exclude the possibility of malignancy by small specimens [9,10]. Therefore, most common esophageal SMTs are not definitely diagnosed until after resection and subsequent pathological examinations.
SMTs larger than 3 cm in diameter suggest the need for treatment due to their high risk of malignancy . Thus, we suggest that if SMT meets the following criteria, surgical resection should be recommended for diagnosis and treatment: (1) the tumor causes symptoms, (2) tumor size is larger than 3 cm, (3) radiologic examination reveals a malignant finding or suspected malignancy, and (4) cytological or pathological examination reveals a malignant finding or suspected malignancy.
Recent advances in thoracoscopic surgery enable us to minimize the procedure to remove SMTs originating from the esophagus. However, enucleation of thoracic esophageal SMTs through a thoracoscopic approach occasionally results in accidental opening of the esophageal mucosa [5,6]. Minimally invasive esophageal surgery such as thoracoscopic esophagectomy with patients in a prone position has demonstrated sufficient short-term outcomes and oncological results . This surgical approach has gained widespread acceptance not only for thoracic esophagectomy but also for enucleation of SMT originating from the thoracic esophagus. Yamada et al. reported thoracoscopic enucleation of esophageal GIST using the prone position with excellent postoperative outcomes . Jeon et al. also demonstrated the safety and efficacy of video-assisted thoracic surgery for enucleation of esophageal submucosal tumors . Furthermore, we combined thoracoscopy with esophagoscopy for maximized complete resection of the tumor, while minimizing exposure of the esophageal lumen by making blue-colored resection layer in the submucosa using endoscopy. Moreover, using our hybrid surgery, thoracoscopic enucleation can be easily performed through only three access ports, which has the advantage of reducing postoperative pain.
This approach is less invasive and safe and facilitates tumor enucleation, resulting in early postoperative recovery. With all these benefits, our hybrid surgical technique has the potential to be highly effective against SMTs originating from the thoracic esophagus, including GISTs.
We thank the members of the Division of Gastrointestinal Endoscopy, National Cancer Center Hospital East.
- Kawamoto K, Yamada Y, Utsunomiya T, Okamura H, Mizuguchi M, Motooka M, et al. Gastrointestinal submucosal tumors: evaluation with endoscopic US. Radiology. 1997;205:733–40.View ArticlePubMedGoogle Scholar
- Tio TL, Tytgat GN, den Hartog Jager FC. Endoscopic ultrasonography for the evaluation of smooth muscle tumors in the upper gastrointestinal tract: an experience with 42 cases. Gastrointest Endosc. 1990;36:342–50.View ArticlePubMedGoogle Scholar
- Asaki S, Hatori S, Nishimura T, Sato A, Okata T, Goto Y. Diagnosis of submucosal tumor by injecting a water soluble contrast medium: development pattern and growing of tumors. Tohoku J Exp Med. 1984;143:385–95.View ArticlePubMedGoogle Scholar
- Eda Y, Asaki S, Yamagata L, Ohrara S, Shibuya D, Toyota T. Endoscopic treatment for submucosal tumors of the esophagus: studies in 25 patients. Gastroenterol Jpn. 1990;25:411–6.PubMedGoogle Scholar
- Gouveia AM, Pimenta AP, Lopes JM, Capelinha AF, Ferreira SS, Valbuena C, et al. Esophageal GIST: therapeutic implications of an uncommon presentation of a rare tumor. Dis Esophagus. 2005;18:70–3.View ArticlePubMedGoogle Scholar
- Milman S, Kim AW, Farlow E, Liptay MJ. Enucleation of a giant esophageal gastrointestinal stromal tumor. Ann Thorac Surg. 2009;87:1603–5.View ArticlePubMedGoogle Scholar
- Daiko H, Nishimura M. A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc. 2012;26:673–80.View ArticlePubMedGoogle Scholar
- Chang WC, Tzao C, Shen DHY, Cheng CY, Yu CP, Hsu HH. Gastrointestinal stromal tumor (GIST) of the esophagus detected by positron emission tomography/computed tomography. Dig Dis Sci. 2005;50:1315–8.View ArticlePubMedGoogle Scholar
- Giovannini M, Seitz JF, Monges G, Perrier H, Rabbia I. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy. 1995;27:171–7.View ArticlePubMedGoogle Scholar
- Wiersema MJ, Wiersema LM, Khusro Q, Cramer HM, Tao LC. Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions. Gastrointest Endosc. 1994;40:199–206.View ArticlePubMedGoogle Scholar
- Yamada H, Shinohara T, Yokoyama K, Takasu K, Fujimori Y, Yamagishi K. Thoracoscopic enucleation of esophageal gastrointestinal stromal tumor using prone positioning in a patient with severe chronic obstructive lung disease. J Laparoendosc Adv Surg Tech A. 2011;21:635–9.View ArticlePubMedGoogle Scholar
- Jeon HW, Choi MG, Lim CH, Park JK, Sung SW. Intraoperative esophagoscopy provides accuracy and safety in video-assisted thoracoscopic enucleation of benign esophageal submucosal tumors. Dis Esophagus. 2014 [Epub ahead of print]Google Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.